femara 2.5 mg film-coated tablets
pco manufacturing ltd. - letrozole - film-coated tablet - 2.5 milligram(s) - aromatase inhibitors; letrozole
letzo 2.5 mg film-coated tablets
rowex ltd - letrozole - film-coated tablet - 2.5 milligram(s) - aromatase inhibitors; letrozole
femolet letrozole 2.5 mg film-coated tablet blister pack
alphapharm pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; sodium starch glycollate; maize starch; magnesium stearate; lactose monohydrate; titanium dioxide; macrogol 8000; hypromellose; triacetin; iron oxide yellow; iron oxide red; quinoline yellow aluminium lake; polydextrose - for the treatment of postmenopausal women with hormone receptor positive breast cancer. the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
femara 2.5 mg film-coated tablets
novartis ireland limited - letrozole - film-coated tablet - 2.5 milligram(s) - aromatase inhibitors; letrozole
femara 2.5 mg film-coated tablets
imed healthcare ltd. - letrozole - film-coated tablet - 2.5 milligram(s) - aromatase inhibitors; letrozole
eirfem 2.5 mg film-coated tablets
rowa pharmaceuticals limited - letrozole - film-coated tablet - 2.5 milligram(s) - aromatase inhibitors; letrozole
pharmacor letrozole 2.5 letrozole 2.5 mg film-coated tablet blister pack
pharmacor pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; maize starch; sodium starch glycollate type a; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; titanium dioxide; purified talc; iron oxide yellow; macrogol 400 - indicated for the treatment of post menopausal women with hormone receptor positive breast cancer. . the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
letrozole gh letrozole 2.5mg film-coated tablet blister pack
cipla australia pty ltd - letrozole, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate; microcrystalline cellulose; hypromellose; colloidal anhydrous silica; magnesium stearate; titanium dioxide; iron oxide yellow; macrogol 400 - for the treatment of postmenopausal women with hormone receptor positive breast cancer (see clinical trials). the safety and efficacy of neoadjuvant use of letrozole has not been established. letrozole is not indicated in hormone receptor negative disease.
letrozole galenicum health 2.5 mg film-coated tablets
galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - film-coated tablet - letrozole 2.5 mg - endocrine therapy
letrozole galenicum 2.5 mg film-coated tablets
galenicum health, s.l.u calle sant gabriel, 50 esplugues de llobregat 08950 barcelona, spain - film-coated tablet - letrozole 2.5 mg - endocrine therapy